nach oben

Indian Journal of Surgical Oncology

Erschienen in:

12.01.2023 | Review Article

Tracking the Development of Cancer Care After 75 Years of Independence: India’s Fight Against Cancer Since 1947

verfasst von: Ashok Mehta

Erschienen in: Indian Journal of Surgical Oncology | Sonderheft 1/2022

Einloggen, um Zugang zu erhalten

Abstract

India is one of the fastest developing countries with tremendous growth in industrialization and healthcare facilities. Research and development in the field of healthcare improved the quality of life and well-being of our population. Despite the availability of healthcare facilities and infrastructure, we are still facing considerable challenges in the prevention, diagnosis, and treatment of cancer. The present review focuses on the history and development of cancer care facilities since independence. The advances in cancer diagnostics for early detection of cancer and developments in the field of conventional surgery, including laparoscopic and robotic surgeries, chemotherapy, and radiation therapy, are reviewed. Immunotherapy, vaccines, and selective targeting of tumor cells using nanotechnology are emerging areas in the field of cancer research.

Siegel R, Naishadham D, Jemal A (2013) Cancer statistics 2013. CA Cancer J Clin 63:11–30. https://doi.org/10.3322/caac.21166 CrossRef

Meacham CE, Morrison SJ (2013) Tumor heterogeneity and cancer cell plasticity. Nature 501:328–337. https://doi.org/10.1038/nature12624 CrossRef

Fisher R, Pusztai L, Swanton C (2013) Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. https://doi.org/10.1038/bjc.2012.581 CrossRef

Dhillon PK, Yeole BB, Dikshit R, Kurkure AP, Bray F (2011) Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over 30 years, 1976–2005: an age-period-cohort analysis. Br J Cancer. https://doi.org/10.1038/bjc.2011.301 CrossRef

Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. 2016. CA Cancer J Clin 66:7–30. https://doi.org/10.3322/caac.21332 CrossRef

D. Schottenfeld, J.F. Fraumeni (2006) Jr. Cancer Epidemiology and Prevention Oxford University Press.

Yoo KY, Shin HR (2003) Cancer epidemiology and prevention. Korean J Epidemiol 25:1–15

Aizawa K, Liu C, Tang S et al (2016) Tobacco carcinogen induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation. IntJ Cancer 139:1171–1181. https://doi.org/10.1002/ijc.30161 CrossRef

Poon SL, McPherson JR, Tan P, Teh BT, Rozen SG (2014) Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med 6:24 CrossRef

10.

Trafialek J, Kolanowski W (2014) Dietary exposure to meat-related carcinogenic substances: is there a way to estimate the risk? Int J Food Sci Nutr 65:774–780. https://doi.org/10.3109/09637486.2014.917146 CrossRef

11.

Antwi SO, Eckert EC, Sabaque CV et al (2015) Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer. Cancer Causes Control 26:1583–1591. https://doi.org/10.1007/s10552-015-0652-y CrossRef

12.

Parkin DM (2006) The global health burden of infection-associated cancers in the year 2000. Int J Cancer 118:3030–3044. https://doi.org/10.1002/ijc.21731 CrossRef

13.

Engelgau MM, Karan A, Mahal A (2012) (2012) The economic impact of non-communicable diseases on households in India. Global Health 8:9 CrossRef

14.

Narielwala FM, Bhat HS, Eapen CK: A Critical study of carcinoma of pancreas incidence, clinical features, laboratory and radiological investigations: Ind J of Cancer Vol.1:p71–90, 1963–64.

15.

Smith RD, Mallath MK (2019) History of the growing burden of cancer in India: from antiquity to the 21st century. J Glob Oncol 5:1–15

16.

Banerjee S, Mukherjee M, Maiti PK (2014) SubodhMitra (2014) The forgotten hero in the Indian radiotherapy. J Can Res Ther 10:793–795

17.

Chaudhry, K. and Luthra, U.K., (2015). Cancer registration in India.WWW page. URL: www. mohfw. nic.in/WriteReadData/l892s/Cancer% 20Registration% 20In% 20India. pdf. Last accessed February,24, p.2016

18.

Indian Council of Medical Research. National Cancer Registry Program. http://www.ncrpindia.org/ (accessed Dec 20, 2013)

19.

Gaikwad PS, Banerjee R (2018) Advances in point-of-care diagnostic devices in cancers. Analyst 143(6):1326–1348 CrossRef

20.

Fass L (2008) Imaging and cancer: a review. Mole Oncol 2(2):115–152. https://doi.org/10.1016/j.molonc.2008.04.001 CrossRef

21.

Griffeth LK (2005) October. Use of PET/CT scanning in cancer patients: technical and practical considerations. InBaylor University Medical Center Proceedings(Vol. 18, No. 4, pp. 321–330). Taylor & Francis https://doi.org/10.1080/08998280.2005.11928089

22.

Matlashewski G, Lamb P, Pim D, Peacock J, Crawford L, Benchimol S (1984) Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene EMBO J, p. 3257 https://doi.org/10.1002/j.1460-2075.1984.tb02287.x

23.

Hassanpour SH, Dehghani M (2017) Review of cancer from perspective of molecular. J Cancer Res Practice 4(4):127–129. https://doi.org/10.1016/j.jcrpr.2017.07.001 CrossRef

24.

Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, Nallasamy V, John A, Narasimhan S, Roselind FS. and ICMR-NCDIR-NCRP Investigator Group, (2020). Cancer statistics, 2020: report from national cancer registry programme, India.JCOGlobal Oncology,6, pp.1063–1075. https://creativecommons.org/licenses/by-nc-nd/4.0/

25.

Frangioni JV (2008) New technologies for human cancer imaging. J Clin Oncol 26(24):4012–4021. https://doi.org/10.1200/JCO.2007.14.3065 CrossRef

26.

Bhattacharyya M et al (2008) Using MRI to plan breast conserving surgery following neoadjuvantchemotherapy for early breast cancer. Br J Cancer 98:289–329. https://doi.org/10.1038/sj.bjc.6604171 CrossRef

27.

Fass L (2008) (2008) Imaging and cancer: a review. Mole Oncol 2(2):115–152. https://doi.org/10.1016/j.molonc.2008.04.001 CrossRef

28.

Burney IA, Al-Moundhri MS (2008) Major advances in the treatment of cancer: what does a non-oncologist need to know? Sultan Qaboos Univ Med J 8(2):137–148

29.

Eisen T, Sternberg CN, Robert C, Mulders P, Pyle L, Zbinden S, Izzedine H and Escudier B, (2012). Targeted therapies for renal cell carcinoma: review of adverse event management strategies. Journal of the National Cancer Institute, 104(2), pp.93–113. https://academic.oup.com/jnci/article/104/2/93/2517204

30.

Fatima S, Lee N.P.Y, Kwan H.Y and Bian Z.X (2017). Emerging Targeted Therapies for Treatment of Hepatocellular Carcinoma (HCC). In hepatocellular carcinoma-advances in diagnosis and treatment. IntechOpen. https://www.intechopen.com/chapters/58248

31.

Lackner M.R, Wilson TR and Settleman J (2012). Mechanisms of acquired resistance to targeted cancer therapies. Future oncology, 8(8), pp.999–1014.https://www.futuremedicine.com/doi/ https://doi.org/10.2217/fon.12.86

32.

Kerr R.S (2020). Surgery in the 2020s: Implications of advancing technology for patients and the workforce. Future Healthcare Journal, 7(1), p.46. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032584/

33.

Paul G.M., Rezaienia A., Wen P., Condoor S., Parkar N., King W. and Korakianitis T (2018). Medical applications for 3D printing: recent developments. Missouri medicine, 115(1), p.75. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139809/

34.

Ventola C.L (2014). Medical applications for 3D printing: current and projected uses. Pharmacy and Therapeutics, 39(10), p.704. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189697/

35.

Pillarisetti R.R. and Querci della Rovere G (2012). Oncoplastic breast surgery. Indian Journal of Surgery, 74(3), pp.255–263. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397185/

36.

Patey DH, Dyson WH (1948) The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Cancer 2:7. https://doi.org/10.1038/bjc.1948.2 CrossRef

37.

Upadyaya P, Dhawan IK, Sidhu S (1965) Replacement of the jaw following excisional surgery for malignant disease of the mandible. IJ Cancer 2:48–54

38.

Behrouzkia Z, Joveini Z, Keshavarzi B, Eyvazzadeh N, Aghdam RZ (2016) Hyperthermia: How Can It Be Used? Oman Med J 31(2):89–97. https://doi.org/10.5001/omj.2016.19 CrossRef

39.

Senapati S, Mahanta AK, Kumar S, Maiti P. (2018) Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3:7. Published Mar 16. doi: https://doi.org/10.1038/s41392-017-0004-3

40.

Chandrasekharan P, Tay ZW, Hensley D, et al. (2020) Using magnetic particle imaging systems to localize and guide magnetic hyperthermia treatment: tracers, hardware, and future medical applications. Theranostics. 10(7):2965–2981. Published 2020 Feb 10. https://doi.org/10.7150/thno.40858

41.

Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG (2012) Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev Clin Pharmacol 5(2):173–186. https://doi.org/10.1586/ecp.12.1 CrossRef

42.

Lahiri BB, Surojit Ranoo AW, Zaibudeen JP (2017) Magnetic hyperthermia in magnetic nanoemulsions: effects of polydispersity, particle concentration and medium viscosity. J Magn Magn Mater 441:310–327. https://doi.org/10.1016/j.jmmm.2017.05.076 CrossRef

43.

Torres-Lugo M, Rinaldi C (2013) Thermal potentiation of chemotherapy by magnetic nanoparticles. Nanomedicine (Lond) 8(10):1689–1707. https://doi.org/10.2217/nnm.13.146 CrossRef

44.

Borghaei H, Smith MR, Campbell KS (2009) Immunotherapy of cancer. Eur J Pharmacol 625(1–3):41–54. https://doi.org/10.1016/j.ejphar.2009.09.067 CrossRef

45.

46.

Jahrsdorfer B, Weiner GJ (2008) CpGoligodeoxynucleotides as immunotherapy in cancer. Update Cancer Ther 3:27–32. https://doi.org/10.1186/s12967-017-1152-5 CrossRef

47.

Choi YE, Kwak JW, Park JW (2010) Nanotechnology for early cancer detection. Sensors (Basel) 10(1):428–455. https://doi.org/10.3390/s100100428 CrossRef

48.

Zhang J, Wang L, You X, Xian T, Wu J, Pang J (2019) Nanoparticle therapy for prostate cancer: overview and perspectives. Curr Top Med Chem 19:57–73. https://doi.org/10.2174/1568026619666190125145836 CrossRef

49.

Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF (2009) An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol 71(8):1185–1198. https://doi.org/10.1111/jphp.13098 CrossRef

50.

Din FU, Aman W, Ullah I, et al. (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine. 12:7291–7309. Published 2017 Oct 5. https://doi.org/10.2147/IJN.S146315

51.

Gadag S, Sinha S, Nayak Y, Garg S, Nayak UY (2020) Combination therapy and nanoparticulate systems: smart approaches for the effective treatment of breast cancer. Pharmaceutics 12(6):524 CrossRef

Titel: Tracking the Development of Cancer Care After 75 Years of Independence: India’s Fight Against Cancer Since 1947
verfasst von: Ashok Mehta
Publikationsdatum: 12.01.2023
Verlag: Springer India
Erschienen in: Indian Journal of Surgical Oncology / Ausgabe Sonderheft 1/2022
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-022-01689-2

Neu im Fachgebiet Chirurgie

17.03.2023 | Rückenmarkstimulation | Nachrichten

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

Tracking the Development of Cancer Care After 75 Years of Independence: India’s Fight Against Cancer Since 1947

Abstract

Neu im Fachgebiet Chirurgie

Epidurale Stimulation stärkt Feinmotorik nach Schlaganfall

10 Jahre nach der Morbus Crohn-Diagnose ist jeder Fünfte darmreseziert

Appendizitis-Verdacht: Ärztliches Gespür trügt selten

Darmperforation durch Obstipation während Chemotherapie

Update Chirurgie

Update Chirurgie

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2022

Palliative Care in India: Past, Present, and Future

Cancer Care—Post-Independence Evolution in West Bengal and Eastern India

Strengthening Cancer Surveillance in India: Role of the National Cancer Registry Programme

Indian Association of Surgical Oncology (IASO)’s Contribution to Cancer Care in India

Reflections on Cancer/Healthcare Landscape in India on the Occasion of 75 Years of Independence: Glorious Past and a Future Filled with Pride and Optimism

Development of Cancer Care in Northeast India

Neu im Fachgebiet Chirurgie

Epidurale Stimulation stärkt Feinmotorik nach Schlaganfall

10 Jahre nach der Morbus Crohn-Diagnose ist jeder Fünfte darmreseziert

Appendizitis-Verdacht: Ärztliches Gespür trügt selten

Darmperforation durch Obstipation während Chemotherapie

Update Chirurgie

Update Chirurgie